Pre-Competition Protocol

Overview

Competitive athletes face a unique challenge in the peptide space: many of the compounds discussed throughout Pepperpedia are on the World Anti-Doping Agency (WADA) Prohibited List and/or prohibited by sport-specific anti-doping organizations. Using these substances in competition — or in many cases, at any time — constitutes a doping violation that can result in suspension, loss of results, financial penalties, and reputational damage.

This protocol is not a guide to evading drug tests. Rather, it serves as an educational resource for competitive athletes to understand which peptides are prohibited, what the detection windows are based on available research, and how to time the discontinuation of any previously used substances relative to competition and testing. The only way to guarantee compliance with anti-doping regulations is complete abstinence from prohibited substances.

For the comprehensive regulatory landscape, see WADA and Peptides. For general sports peptide research, see Peptides in Sports.

WADA Classification of Common Peptides

The WADA Prohibited List categorizes substances by class. The following table summarizes the status of peptides commonly discussed on this site:

Prohibited At All Times (In- and Out-of-Competition)

The S0 Category

WADA's S0 category ("Non-Approved Substances") is a catch-all that prohibits any pharmacological substance not addressed by any of the other sections of the Prohibited List and with no current approval by any governmental regulatory health authority for human therapeutic use. This effectively prohibits most research peptides regardless of whether they are specifically named on the list.

Key principle: If a peptide does not have regulatory approval for human use (FDA, EMA, etc.) in any country, it is prohibited under S0. This captures the vast majority of peptides discussed in the research peptide community.

Detection Windows

Detection windows vary significantly based on the compound, dose, duration of use, individual metabolism, and the analytical method employed. Anti-doping laboratories continually improve their detection capabilities, and published detection windows should be considered minimum estimates.

Critical caveat: These windows are approximate and based on limited published data. Anti-doping science advances continuously. A substance may be detected long after the estimated window by newer analytical methods. Do not rely on detection windows for compliance — rely on abstinence.

Pre-Competition Decision Framework

Decision 1: Identify Your Testing Framework

Different competitive levels have different testing regimes:

Decision 2: Cessation Timeline

For athletes who have used prohibited peptides and are transitioning to competition:

Conservative approach (recommended):

• Discontinue ALL prohibited substances minimum 6 months before the first possible test
• For natural bodybuilding/powerlifting federations with extended lookback periods, some require 7–10 years drug-free
• For Athlete Biological Passport (ABP) monitored athletes, longitudinal biomarker changes can flag prior use even when the substance is no longer detectable

Absolute minimum approach (high risk):

• Short-acting peptides (GHSs, Selank, Semax): Minimum 2 weeks, though this provides no safety margin
• Longer-acting compounds (MK-677, semaglutide): Minimum 4–6 weeks
• BPC-157, TB-500: Unknown detection windows; no reliable minimum can be established

Decision 3: Permitted Alternatives

Athletes can employ non-prohibited strategies for recovery, performance, and health:

Therapeutic Use Exemptions (TUEs)

Athletes with legitimate medical conditions requiring prohibited substances can apply for a Therapeutic Use Exemption. Requirements:

1. The athlete would experience significant health impairment without the substance
2. The substance will not produce significant performance enhancement beyond returning to normal health
3. There is no reasonable permitted therapeutic alternative
4. The necessity is not due to prior use of a prohibited substance

TUE applications are reviewed by a panel of physicians (TUE Committee). Common TUE examples relevant to peptides include teriparatide for severe osteoporosis and insulin for type 1 diabetes. TUEs for growth hormone, testosterone, or similar performance-relevant compounds face much higher scrutiny.

Important Considerations

• Strict liability: Under WADA rules, athletes are strictly liable for substances found in their body. "I didn't know it was prohibited" is not a defense. Ignorance of the rules does not prevent a violation.
• Supplement contamination: Many dietary supplements contain undeclared prohibited substances. Competitive athletes should only use supplements certified by third-party testing programs (NSF Certified for Sport, Informed Sport, BSCG). See Purity and Testing.
• The Prohibited List changes annually: Always check the current year's WADA Prohibited List. Substances can be added or removed.
• Legal vs. anti-doping: A substance can be legal to purchase and possess but still prohibited under anti-doping rules. Legality and sporting permissibility are separate domains.
• This is not legal advice: Anti-doping regulations are complex and jurisdiction-specific. Athletes subject to testing should consult with a sports lawyer or their national anti-doping organization for specific guidance.
• When in doubt, do not use it. The consequences of a positive test — even an inadvertent one — are severe and long-lasting.

Disclaimer

This article is for educational and informational purposes only. It does not constitute medical or legal advice, and no claims are made about the ability to pass drug tests using any timing strategy. Anti-doping rules are strict liability — athletes are responsible for everything in their body regardless of intent. Consult with anti-doping authorities and legal counsel for specific guidance. All compounds discussed are referenced for research and educational purposes only.